Pharmaceutical Care Management Association | PCMA

PBM Innovations

PBM Innovations: Putting Patients at the Center

PBMs are not waiting for government interventions or unnecessary mandates to innovate and adapt to changing market conditions to help patients.

How PBMs Work

How PBMs Work

PBMs Work At the Center of Health and Savings

‍Pharmacy benefit companies are working every day on behalf of employers and health plans to secure savings on prescription drugs, enable better health outcomes for patients, and support access to quality prescription drug coverage for more than 275 million patients.

PCMA Newsroom

LATEST NEWS

The Latest Press Releases, Statements, and Blogs

PCMA Conferences

PCMA hosts two annual conferences exclusively for our members, sponsors and their affiliated business partners

Thought Leadership

Pharma: Lower The List Price

Big Pharma Sets the Price of the Prescription Drugs

Big Pharma sets the price of the prescription drugs — and the price is the problem when it comes to Americans facing difficulty affording their prescription drugs.Big drug companies determine the price, decide when to increase the price, block competition to keep the price high and increase sales by spending billions of dollars each year advertising high-priced products to consumers.

Stepping Toward a More Affordable Future

Stepping Toward a More Affordable Future

PBMs provide $145 billion in value for the U.S. health care system annually by lowering prescription drug costs. Additionally, PBMs enable better health outcomes for patients and offer employers and other health insurance plan sponsors the choices and guidance they need to expand access and provide quality prescription drug coverage for millions of Americans.

PBMs and Pharmacies

PBMs AND PHARMACIES

Each year, PBMs save patients and the U.S. health care system an average of $1,040 per person. Without PBMs, employers and health plans would be forced to go it alone on pharmacy benefits, which would result in significantly higher drug costs for patients.

Drug Companies Continue to Set High Prescription Drug Launch Prices

Drug Companies Continue to Set High Prescription Drug Launch Prices

High list prices on brand prescription drugs continue to be a challenge for payers and patients. PBMs applauded when certain drug companies brought down the prices of treatments of some chronic conditions such as asthma and diabetes. But more needs to be done.

Health Equity

Health Equity

Pharmacy benefit companies, in collaboration with plan sponsors, clinicians, and government programs, have a long history of working to advance health equity.